OH2 Oncolytic Viral Therapy in Solid Tumors

Clinical trial NCT03866525 · RECRUITING

Trial details

NCT number: NCT03866525
Sponsor: Binhui Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Gastrointestinal Cancer

Start date: 2019-04-02
Primary completion: 2025-08-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.